ARN-MANCT06523296
Presence of Anti-RACH Antibodies and Neurocognitive Disorder in Myasthenic or Alzheimers's Patients.
StatusTerminated
PhaseNot applicable
Primary completion
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗
Stopped Trial terminated Sponsor's reason: recruitment challenges Show 5 more changesShow less
- Final enrollment: 1 participants, 3% of the 30 planned
- Eligibility criteria expanded, about 16 words
- Primary completion date changed from estimate of Aug 18, 2028 to Aug 18, 2026
- Interventions: Adults with Alzheimer's disease (Procedure), Adults with Myasthenia (Procedure), Healhty controls (Other) to Adults with Alzheimer's disease (Procedure), Adults with Myasthenia (Procedure), Healhty controls (Other)
- Site details revised
- Notable Primary completion pushed from May 1, 2026 to Aug 18, 2028
- Start date: Apr 17, 2024 to Aug 18, 2026
- Study completion pushed from Jun 1, 2026 to Sep 18, 2028
- Minor Primary completion date: Oct 1, 2026 to May 1, 2026
- Study completion date: Nov 1, 2026 to Jun 1, 2026
- Start date changed from estimate of Sep 17, 2024 to Apr 17, 2024
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date: Oct 1, 2024 to Sep 17, 2024
- Site details revised
- Notable Primary endpoint revisedv2
- Study First Submitted
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
The ratio of the number of myasthenic patients with NS-NCD that may be related to myasthenia-related central nervous system damage to the total number of myasthenic patients with CND from all causes combined.
Timeframe: at day 0
Secondary (2)
Measurement of RACH antibodies in serum
Measurement of RACH antibodies in cerebrospinal liquid
Arms and interventions
Adults with Alzheimer's diseaseExperimental
Adults with MyastheniaExperimental
healthy volonteerExperimental
Procedures: Adults with Alzheimer's disease, Adults with Myasthenia
Other: Healhty controls
Sites
1 site in 1 country
- CHU de NiceNice, Alpes Maritimes, France